21.1 C
Delhi
Wednesday, November 5, 2025

Tag: gene editing safety

Intellia Pauses CRISPR Trial After Patient Liver Reaction

Intellia Therapeutics halts Phase 3 gene therapy trials after participant develops severe liver complications. Learn about the safety pause and implications.